Morning Overview on MSN
The FDA approved a lower-dose contrast agent to cut patients’ exposure during MRI scans
Patients who need repeated MRI scans with contrast dye could soon receive a fraction of the gadolinium they currently get. The FDA approved gadoquatrane, a new gadolinium-based contrast agent designed ...
The Arizona Diamondbacks have made it through the month of June above .500, and just beat the Giants whose PR storm continues ...
Emerging leaders in the field of contrast-enhanced ultrasound (CEUS) are invited to submit scientific posters, and to compete for $1,000 educational scholarships and the opportunity to present their ...
ProPublica conducted a new analysis that shows the court is deciding more consequential rulings than ever before in largely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results